Compare SRPT & MD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRPT | MD |
|---|---|---|
| Founded | 1980 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.0B |
| IPO Year | 1997 | 1995 |
| Metric | SRPT | MD |
|---|---|---|
| Price | $21.00 | $24.18 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 28 | 4 |
| Target Price | ★ $26.00 | $21.00 |
| AVG Volume (30 Days) | ★ 6.1M | 1.3M |
| Earning Date | 11-03-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.91 |
| Revenue | ★ $2,413,715,000.00 | $1,922,442,000.00 |
| Revenue This Year | $10.20 | N/A |
| Revenue Next Year | N/A | $2.73 |
| P/E Ratio | ★ N/A | $12.62 |
| Revenue Growth | ★ 47.15 | N/A |
| 52 Week Low | $10.42 | $11.84 |
| 52 Week High | $138.81 | $24.99 |
| Indicator | SRPT | MD |
|---|---|---|
| Relative Strength Index (RSI) | 56.81 | 76.84 |
| Support Level | $15.94 | $22.65 |
| Resistance Level | $21.21 | $24.00 |
| Average True Range (ATR) | 1.26 | 0.77 |
| MACD | 0.42 | 0.03 |
| Stochastic Oscillator | 96.02 | 78.30 |
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.